Testing effectiveness (Phase 2)Study completedNCT03936452
What this trial is testing
Combined Treatment of Sintilimab, Peg-aspargase Plus Anlotinib in NK/T Cell Lymphoma
Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeEarly StageAnlotinib+5 more
Sun Yat-sen University 55